NO945015L - Substituerte 1-okso-1,2-dihydro-isochinolinoyl- og 1,1-diokso-2H-1,2-benzotiazinoylguanidiner, fremgangsmåte for fremstilling og anvendelse som medikament eller diagnostikum - Google Patents
Substituerte 1-okso-1,2-dihydro-isochinolinoyl- og 1,1-diokso-2H-1,2-benzotiazinoylguanidiner, fremgangsmåte for fremstilling og anvendelse som medikament eller diagnostikumInfo
- Publication number
- NO945015L NO945015L NO945015A NO945015A NO945015L NO 945015 L NO945015 L NO 945015L NO 945015 A NO945015 A NO 945015A NO 945015 A NO945015 A NO 945015A NO 945015 L NO945015 L NO 945015L
- Authority
- NO
- Norway
- Prior art keywords
- dihydroisoquinolinoyl
- benzothiazinoylguanidines
- dioxo
- oxo
- medicament
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Compression, Expansion, Code Conversion, And Decoders (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4344550A DE4344550A1 (de) | 1993-12-24 | 1993-12-24 | Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO945015D0 NO945015D0 (no) | 1994-12-23 |
| NO945015L true NO945015L (no) | 1995-06-26 |
| NO304787B1 NO304787B1 (no) | 1999-02-15 |
Family
ID=6506276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944747A NO304787B1 (no) | 1993-12-24 | 1994-12-23 | Substituerte 1-okso-1,2-dihydro-isochinolinoyl- og 1,1-diokso-2H-1,2-benzotiazinoylguanidiner og anvendelse av forbindelsene for fremstilling av medikamenter |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5547953A (no) |
| EP (1) | EP0659748B1 (no) |
| JP (1) | JP3790559B2 (no) |
| KR (2) | KR100360127B1 (no) |
| CN (1) | CN1053899C (no) |
| AT (1) | ATE194605T1 (no) |
| AU (1) | AU683320B2 (no) |
| CA (1) | CA2138466A1 (no) |
| DE (2) | DE4344550A1 (no) |
| DK (1) | DK0659748T3 (no) |
| ES (1) | ES2149233T3 (no) |
| FI (1) | FI946039A (no) |
| GR (1) | GR3034335T3 (no) |
| HU (1) | HU222524B1 (no) |
| IL (1) | IL112114A (no) |
| NO (1) | NO304787B1 (no) |
| NZ (2) | NZ270264A (no) |
| PT (1) | PT659748E (no) |
| TW (1) | TW504505B (no) |
| ZA (1) | ZA9410242B (no) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0765867A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
| DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
| DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
| CA2195697A1 (en) * | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
| JPH10152481A (ja) * | 1996-09-25 | 1998-06-09 | Kanebo Ltd | ベンゾ［１，４］チアジン誘導体およびそれからなる医薬 |
| AU6435098A (en) * | 1997-02-12 | 1998-08-26 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| US6436927B1 (en) | 1997-02-12 | 2002-08-20 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6258829B1 (en) | 1997-03-06 | 2001-07-10 | Toa Eiyo Ltd. | Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same |
| JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体 |
| DE10163914A1 (de) * | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| US6703405B2 (en) | 2001-12-22 | 2004-03-09 | Aventis Pharma Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them |
| WO2006044645A2 (en) | 2004-10-13 | 2006-04-27 | Adolor Corporation | Sulfamoyl benzamides and methods of their use |
| DK2648511T3 (en) | 2010-12-08 | 2017-09-18 | Lycera Corp | PYRAZOLYLGUANIDINE-F1F0 ATPASE INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF |
| EP2648710B1 (en) | 2010-12-08 | 2016-06-15 | Lycera Corporation | Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| US9169199B2 (en) | 2010-12-08 | 2015-10-27 | Lycera Corporation | Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof |
| WO2013185045A1 (en) | 2012-06-08 | 2013-12-12 | Lycera Corporation | Indazole guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| WO2013185048A2 (en) | 2012-06-08 | 2013-12-12 | Lycera Corporation | Heterocyclic guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| US9580391B2 (en) | 2012-06-08 | 2017-02-28 | Lycera Corporation | Saturated acyl guanidine for inhibition of F1F0-ATPase |
| BR112016013116A8 (pt) | 2013-12-10 | 2020-05-12 | Lycera Corp | inibidores de trifluorometil pirazolil guanidina f1f0-atpase, seus usos, e composições farmacêuticas |
| EP3080088B1 (en) | 2013-12-10 | 2019-07-31 | Lycera Corporation | Alkylpyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| EP3080087B1 (en) | 2013-12-10 | 2019-05-22 | Lycera Corporation | N-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| DK0556674T3 (da) * | 1992-02-15 | 1996-10-14 | Hoechst Ag | 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation |
| DE59305042D1 (de) * | 1992-09-22 | 1997-02-20 | Hoechst Ag | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
| PT590455E (pt) * | 1992-09-28 | 2001-04-30 | Hoechst Ag | 1(2h)-isoquinolinas substituidas anti-arritmicas e cardioprotectoras processo para a sua preparacao medicamento contendo estes compostos e sua utilizacao para a preparacao de um medicamento para o combate de falhas cardiacas |
| TW250479B (no) * | 1992-12-15 | 1995-07-01 | Hoechst Ag |
-
1993
- 1993-12-24 DE DE4344550A patent/DE4344550A1/de not_active Withdrawn
-
1994
- 1994-11-21 TW TW083110790A patent/TW504505B/zh not_active IP Right Cessation
- 1994-12-19 PT PT94120069T patent/PT659748E/pt unknown
- 1994-12-19 DE DE59409439T patent/DE59409439D1/de not_active Expired - Lifetime
- 1994-12-19 AT AT94120069T patent/ATE194605T1/de not_active IP Right Cessation
- 1994-12-19 EP EP94120069A patent/EP0659748B1/de not_active Expired - Lifetime
- 1994-12-19 CA CA002138466A patent/CA2138466A1/en not_active Abandoned
- 1994-12-19 DK DK94120069T patent/DK0659748T3/da active
- 1994-12-19 ES ES94120069T patent/ES2149233T3/es not_active Expired - Lifetime
- 1994-12-22 US US08/362,003 patent/US5547953A/en not_active Expired - Lifetime
- 1994-12-22 FI FI946039A patent/FI946039A/fi not_active Application Discontinuation
- 1994-12-22 NZ NZ270264A patent/NZ270264A/en unknown
- 1994-12-22 AU AU81700/94A patent/AU683320B2/en not_active Ceased
- 1994-12-22 HU HU9403759A patent/HU222524B1/hu not_active IP Right Cessation
- 1994-12-22 ZA ZA9410242A patent/ZA9410242B/xx unknown
- 1994-12-22 JP JP31959294A patent/JP3790559B2/ja not_active Expired - Fee Related
- 1994-12-22 IL IL11211494A patent/IL112114A/en not_active IP Right Cessation
- 1994-12-22 NZ NZ272846A patent/NZ272846A/en unknown
- 1994-12-22 CN CN94119193A patent/CN1053899C/zh not_active Expired - Fee Related
- 1994-12-23 NO NO944747A patent/NO304787B1/no unknown
- 1994-12-24 KR KR1019940036497A patent/KR100360127B1/ko not_active IP Right Cessation
-
2000
- 2000-09-06 GR GR20000402023T patent/GR3034335T3/el not_active IP Right Cessation
-
2002
- 2002-03-25 KR KR1020020016125A patent/KR100353339B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE59409439D1 (de) | 2000-08-17 |
| CN1053899C (zh) | 2000-06-28 |
| AU683320B2 (en) | 1997-11-06 |
| CA2138466A1 (en) | 1995-06-25 |
| ZA9410242B (en) | 1995-08-02 |
| IL112114A0 (en) | 1995-03-15 |
| DK0659748T3 (da) | 2000-10-02 |
| NZ270264A (en) | 1996-02-27 |
| CN1107840A (zh) | 1995-09-06 |
| PT659748E (pt) | 2000-11-30 |
| NO304787B1 (no) | 1999-02-15 |
| HUT72749A (en) | 1996-05-28 |
| FI946039A (fi) | 1995-06-25 |
| DE4344550A1 (de) | 1995-06-29 |
| KR950017981A (ko) | 1995-07-22 |
| NZ272846A (en) | 1996-02-27 |
| IL112114A (en) | 2001-06-14 |
| EP0659748A1 (de) | 1995-06-28 |
| ATE194605T1 (de) | 2000-07-15 |
| JPH07206823A (ja) | 1995-08-08 |
| HU9403759D0 (en) | 1995-02-28 |
| NO945015D0 (no) | 1994-12-23 |
| US5547953A (en) | 1996-08-20 |
| JP3790559B2 (ja) | 2006-06-28 |
| FI946039A0 (fi) | 1994-12-22 |
| GR3034335T3 (en) | 2000-12-29 |
| HU222524B1 (hu) | 2003-08-28 |
| AU8170094A (en) | 1995-06-29 |
| KR100360127B1 (ko) | 2003-04-23 |
| ES2149233T3 (es) | 2000-11-01 |
| EP0659748B1 (de) | 2000-07-12 |
| TW504505B (en) | 2002-10-01 |
| KR100353339B1 (ko) | 2002-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO945015D0 (no) | Substituerte 1-oxo-1,2-dihydro-isochinolinoyl- og 1,1-dioxo-2H-1,2-benzotiazinoylguanidiner, fremgangsmåte for fremstilling og anvendelse som medikament eller diagnostikum | |
| DK0612723T3 (da) | Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf | |
| ATE205390T1 (de) | Verbesserung der glukosetoleranz | |
| DK159322C (da) | Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden | |
| NZ238181A (en) | N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions | |
| FI920271A0 (fi) | Polyamintioler som straolningsskyddande aemnen. | |
| NO934634L (no) | 3,5-substiturete aminobenzoylguanidiner, fremgangsmåte til fremstilling derav, deres anvendelse som medikament eller diagnostikum samt middel inneholdende forbindelsene | |
| BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
| ES2066060T3 (es) | Solucion humectada para impresion litografica. | |
| CO4290351A1 (es) | Proceso | |
| ATE192141T1 (de) | Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung | |
| DE59107500D1 (de) | Neue Beta-Galactosidase-Substrate für den CEDIA | |
| BR8208033A (pt) | Processo quimico | |
| KR910000645A (ko) | 개선된 경련치료제 | |
| NO943861D0 (no) | Trisyklisk forbindelse til bruk som tachykinin-antagonist | |
| DK289587D0 (da) | Agrokemisk mikrobicid | |
| NO983609L (no) | N-(3,3-dimetylbutyl)-L-aspartyl-D-<alfa>-aminoalkansyre-N-(S)-1-fenyl-alkanamid anvendelig som s°tningsmiddel | |
| DE3462030D1 (en) | Derivatives of beta-û2-(halogenobenzyl)-phenoxy¨- ethylamine,process for their preparation and their therapeutical use. | |
| NO942350L (no) | Peptidforbindelse med terapeutisk aktivitet |